A Study of Disease Progression in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration
Public ClinicalTrials.gov record NCT02479386. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Prospective Epidemiologic Study of The Progression of Geographic Atrophy Secondary to Age-Related Macular Degeneration
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study seeks to better characterize relationships between visual function and the progression (worsening) of geographic atrophy (GA) due to age-related macular degeneration (AMD). The study is also intended to generate new information on the relationship between genetics and GA progression. This is a global, prospective, multicenter, epidemiologic study enrolling participants with GA secondary to AMD. The study visits are scheduled to occur every 6 months. The anticipated duration of the study is up to 48 months. There is a planned interim analysis around the 2-year time window for the study.
Study identification
- NCT ID
- NCT02479386
- Recruitment status
- Terminated
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 296 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 50 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 24, 2015 (Actual)
- Primary completion
- Apr 14, 2017 (Actual)
- Completion
- Jan 31, 2018 (Actual)
- Last update posted
- Aug 26, 2026
2015 – 2018
United States locations
- U.S. sites
- 23
- U.S. states
- 14
- U.S. cities
- 22
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Northwest Arkansas Retina Associates | Springdale | Arkansas | 72764 | — |
| Retinal Diagnostic Center | Campbell | California | 95008 | — |
| Specialty Eye Care Medical Center | Glendale | California | 91203 | — |
| Jules Stein Eye Institute/ UCLA | Los Angeles | California | 90095-7000 | — |
| East Bay Retina Consultants | Oakland | California | 94609 | — |
| Colorado Retina Associates, PC | Golden | Colorado | 80401 | — |
| Rand Eye | Deerfield Beach | Florida | 33064 | — |
| Bascom Palmer Eye Institute | Naples | Florida | 34103 | — |
| Center For Sight | Sarasota | Florida | 34239 | — |
| Rush University Medical Center | Chicago | Illinois | 60612 | — |
| Paducah Retinal Center | Paducah | Kentucky | 42001 | — |
| Greater Baltimore Medical Center | Baltimore | Maryland | 21204 | — |
| Foundation for Vision Research | Grand Rapids | Michigan | 49546 | — |
| MaculaCare, PLLC | New York | New York | 10021 | — |
| Vitreous-Retina-Macula | New York | New York | 10022 | — |
| University of North Carolina; Kittner Eye Center | Chapel Hill | North Carolina | 27517 | — |
| Char Eye Ear &Throat Assoc | Charlotte | North Carolina | 28210 | — |
| Duke University Eye Center; Vitreoretinal | Durham | North Carolina | 27710 | — |
| Scheie Eye Institute | Philadelphia | Pennsylvania | 19104 | — |
| Palmetto Retina Center | Florence | South Carolina | 29501 | — |
| Retina Consultants of Houston | Houston | Texas | 77030 | — |
| Med Center Ophthalmology Assoc | San Antonio | Texas | 78240 | — |
| Wagner Macula & Retina Center | Norfolk | Virginia | 23451 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 68 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02479386, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 26, 2026 · Synced Oct 18, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02479386 live on ClinicalTrials.gov.